Aehr Test Systems (AEHR) EBITDA (2010 - 2026)

Aehr Test Systems has reported EBITDA for 17 years, with the latest figure at -$4.2 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA fell 277.93% year-over-year to -$4.2 million; the trailing twelve-month figure through Feb 2026 stood at -$16.1 million (down 23845.59% YoY), and the FY2025 full-year result was -$5.7 million, down 156.33% from the prior year.
• EBITDA for Q1 2026 stood at -$4.2 million, up from -$4.6 million in the prior quarter.
• The five-year high for EBITDA was $5.8 million in Q2 2022, with the low at -$4.6 million in Q4 2025.
• Historically, EBITDA has averaged $759352.9 across 5 years, with a median of $458000.0 in 2022.
• Annual changes were most pronounced in 2022 — EBITDA surged 868.39% — and 2025, when it sank 2657.23%.
• Aehr Test Systems' EBITDA stood at $3.5 million in 2022, then surged by 56.9% to $5.5 million in 2023, then tumbled by 127.67% to -$1.5 million in 2024, then plunged by 207.2% to -$4.6 million in 2025, then grew by 9.01% to -$4.2 million in 2026.
• The last three EBITDA figures came in at -$4.2 million (Q1 2026), -$4.6 million (Q4 2025), and -$4.1 million (Q3 2025), per Business Quant data.